Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

1.

Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer.

Clarke G, Ryan E, Crowe J, O'Keane JC, MacMathúna P.

Eur J Histochem. 1999;43(4):311-6.

PMID:
10682269
[PubMed - indexed for MEDLINE]
2.

The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome.

Clarke G, Ryan E, O'Keane JC, Crowe J, MacMathuna P.

Eur J Gastroenterol Hepatol. 2000 May;12(5):549-52.

PMID:
10833099
[PubMed - indexed for MEDLINE]
3.

Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.

Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr.

Cancer. 1994 Feb 1;73(3):563-9.

PMID:
7507795
[PubMed - indexed for MEDLINE]
4.

Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer.

Sundov Z, Tomić S, Vilović K, Kunac N, Kalebić M, Bezić J.

Croat Med J. 2008 Oct;49(5):636-42.

PMID:
18925697
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients.

Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowicz E, Guillem JG, Cordon-Cardo C, Cohen AM.

J Clin Oncol. 1994 Oct;12(10):2043-50.

PMID:
7931472
[PubMed - indexed for MEDLINE]
Free Article
6.

Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.

Nasif WA, Lotfy M, El-Sayed IH, El-Kenawy Ael-M, El-Shahat M, El-Hak NG.

Med Oncol. 2006;23(2):237-44.

PMID:
16720924
[PubMed - indexed for MEDLINE]
7.

For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.

Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC.

Cancer. 1998 Aug 15;83(4):666-72.

PMID:
9708929
[PubMed - indexed for MEDLINE]
8.

Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.

Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, Regina G, Roncoroni L.

Eur J Cancer. 2005 Jan;41(2):272-9.

PMID:
15661553
[PubMed - indexed for MEDLINE]
9.

Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.

Gervaz P, Bouzourene H, Cerottini JP, Chaubert P, Benhattar J, Secic M, Wexner S, Givel JC, Belin B.

Dis Colon Rectum. 2001 Mar;44(3):364-72; discussion 372-3.

PMID:
11289282
[PubMed - indexed for MEDLINE]
10.

Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.

Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.

Anticancer Res. 2001 Jan-Feb;21(1A):253-9.

PMID:
11299743
[PubMed - indexed for MEDLINE]
11.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
[PubMed - indexed for MEDLINE]
12.

Tumour-derived mutated K-ras codon 12 expression in regional lymph nodes of stage II colorectal cancer patients is not associated with increased risk of cancer-related death.

Clarke GA, Ryan E, Crowe JP, O'Keane JC, MacMathúna P.

Int J Colorectal Dis. 2001 Apr;16(2):108-11.

PMID:
11355316
[PubMed - indexed for MEDLINE]
13.

Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival.

Nitti D, Belluco C, Montesco MC, Bertorelle R, Da Pian PP, Fassina A, Ninfo V, Chieco-Bianchi L, Lise M.

Eur J Cancer. 1998 May;34(6):851-5.

PMID:
9797697
[PubMed - indexed for MEDLINE]
14.

Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.

Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, Bechi P, Cortesini C.

World J Surg. 2002 Mar;26(3):384-9. Epub 2002 Jan 15.

PMID:
11865379
[PubMed - indexed for MEDLINE]
15.

Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer.

Togo N, Ohwada S, Sakurai S, Toya H, Sakamoto I, Yamada T, Nakano T, Muroya K, Takeyoshi I, Nakajima T, Sekiya T, Yamazumi Y, Nakamura T, Akiyama T.

World J Gastroenterol. 2008 Aug 21;14(31):4880-8.

PMID:
18756595
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and Survival.

Gu CD, Osaki T, Oyama T, Inoue M, Kodate M, Dobashi K, Oka T, Yasumoto K.

Ann Surg. 2002 Jan;235(1):133-9.

PMID:
11753052
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.

Lim YJ, Kim YH, Ahn GH, Chun HK, Jang WY, Lee JH, Son HJ, Rhee PL, Kim JJ, Paik SW, Yoo BC, Rhee JC.

Korean J Gastroenterol. 2004 Dec;44(6):314-20.

PMID:
15665575
[PubMed - indexed for MEDLINE]
Free Article
18.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
[PubMed - indexed for MEDLINE]
19.

Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer.

Kaifi JT, Yekebas EF, Schurr P, Obonyo D, Wachowiak R, Busch P, Heinecke A, Pantel K, Izbicki JR.

J Natl Cancer Inst. 2005 Dec 21;97(24):1840-7.

PMID:
16368946
[PubMed - indexed for MEDLINE]
Free Article
20.

Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer.

Berberoglu U.

Hepatogastroenterology. 2004 Nov-Dec;51(60):1689-93.

PMID:
15532806
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk